Polyclonal antibody-induced downregulation of HER1/EGFR and HER2 surpasses the effect of combinations of specific registered antibodies

Overview of attention for article published in Frontiers in oncology, November 2022

Altmetric Badge

About this Attention Score

Average Attention Score compared to outputs of the same age
Good Attention Score compared to outputs of the same age and source (72nd percentile)

Mentioned by

twitter: 4 X users

Readers on

mendeley: 6 Mendeley

Summary X

So far, Altmetric has seen 4 X posts from 4 X users, with an upper bound of 26,171 followers.

Polyclonal antibody-induced downregulation of HER1/EGFR and HER2 surpasses the effect of combinations of specific registered antibodies https://t.co/EuRAwe6Wyn

22 Nov 2022

Reply Repost Favourite

Polyclonal antibody-induced downregulation of HER1/EGFR and HER2 surpasses the effect of combinations of specific registered antibodies https://t.co/gNge6W0kl5

21 Nov 2022

Reply Repost Favourite

Polyclonal antibody-induced downregulation of HER1/EGFR and HER2 surpasses the effect of combinations of specific registered antibodies https://t.co/sa5KheaLdH https://t.co/mQmFJIk13f

03 Nov 2022

Reply Repost Favourite

New research: Polyclonal antibody-induced downregulation of HER1/EGFR and HER2 surpasses the effect of combinations of specific registered antibodies: Background Antitumor therapies targeting HER1/EGFR and HER2, such as monoclonal antibodies… https://t.co

02 Nov 2022

Reply Repost Favourite

This page shows the most recent X posts that mention this research output.

Click here to find out how to access more activity.